Mod­er­na, IBM turn to quan­tum com­put­ing in hunt for new mR­NA med­i­cines

Mod­er­na plans to build a “quan­tum-ready work­force,” in CEO Stéphane Ban­cel’s words, with the help of glob­al tech con­glom­er­ate IBM, the com­pa­nies said Thurs­day morn­ing.

As the Cam­bridge, MA-based biotech ex­pands be­yond Covid-19 vac­cines and in­to flu, RSV and oth­er dis­ease ar­eas, Mod­er­na plans to em­ploy quan­tum com­put­ing and gen­er­a­tive AI to make new mR­NA med­i­cines, op­ti­mize lo­gis­tics and do what a “clas­si­cal com­put­er” can’t. Gen­er­a­tive AI is now din­ner-par­ty fod­der thanks to the ar­rival of Chat­G­PT late last year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER